Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PSMA Specific [68Ga]-P137 Peptide Probe for PET Imaging in Prostate Cancer

NCT04560725 is registered in ClinicalTrials.gov with Peking University Cancer Hospital & Institute as lead sponsor.

NCT NCT04560725
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04560725 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PSMA Specific [68Ga]-P137 Peptide Probe for PET Imaging in Prostate Cancer
Lead sponsor
Peking University Cancer Hospital & Institute
Phase
Not applicable
Overall status
Active, not recruiting
Start date
October 22, 2020
Completion date
December 1, 2024
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer